Percheron Therapeutics Ltd Cash Flow Quality Index
Percheron Therapeutics Ltd cash flow quality index. Percheron Therapeutics Ltd (PER) has a Cash Flow Quality Index of -0.84x as of June 2025. Operating cash flow of AU$-7.16 Million is below net income of AU$8.54 Million, suggesting accrual-heavy earnings not yet converted to cash. See PER financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Percheron Therapeutics Ltd (2015–2015)
Cash flow quality index of Percheron Therapeutics Ltd from 2015 to 2015. Historical Cash Flow Quality Index for Percheron Therapeutics Ltd across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore how well can Percheron Therapeutics Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
Percheron Therapeutics Ltd Cash Flow Quality Index by Year (2015–2015)
Percheron Therapeutics Ltd cash flow quality index by year from 2015 to 2015. Year-by-year earnings quality comparison for Percheron Therapeutics Ltd. For the full cash flow conversion analysis, see cash flow conversion of Percheron Therapeutics Ltd.
| Year | Quality Index | Operating CF (AUD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2015 | 1.79x | AU$1.27 Million | AU$706.92K | — |